MAPT and Brain atrophy: Using an established model of tau propagation (Thy1-hTau.P301S mice intracerebrally inoculated with tau [1]), we chronically treated mice with a pharmacological AQP4 inhibitor, TGN-020, and evaluated the extent of tau pathology and spread, together with the resultant effects on regional brain atrophy, and changes in behaviour.